D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
about
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learningHow do the atypical antipsychotics work?Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivityDistinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the ratAltered striatal function in a mutant mouse lacking D1A dopamine receptorsAdenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient miceAnimal models of tic disorders: a translational perspective.An update on the connections of the ventral mesencephalic dopaminergic complex.Does the difference between physically active and couch potato lie in the dopamine system?Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.What is the Degree of Segregation between Striatonigral and Striatopallidal Projections?Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism.Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features.A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewalDeciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling.Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine.Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice.The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum.Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training.Understanding decision-making deficits in neurological conditions: insights from models of natural action selection.Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilatChronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of ratsDopamine D1-like and D2-like receptors in the dorsal striatum control different aspects of attentional performance in the five-choice serial reaction time task under a condition of increased activity of corticostriatal inputs.Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptorMaturation of coordinated immediate early gene expression by cocaine during adolescenceStriatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression.Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Dopamine receptor signaling and current and future antipsychotic drugs.ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions.Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.Pitfalls in assessment of c-fos mRNA expression in the brain: effects of animal handling.Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons.Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system.Anatomical and functional reconstruction of the nigrostriatal system in vitro: selective innervation of the striatum by dopaminergic neurons.Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors.
P2860
Q24305024-93691AB9-238F-4304-B22D-1F181986DE13Q24674131-5E8DDD84-54D2-4E95-9EBC-3E9D063C0783Q28344179-8A6EDE49-A4C3-4C79-B7B5-D687D56024BEQ28369508-09E0553E-A83F-4A1E-A3B9-0CE18ECB8365Q28575496-CB647ACD-CFC9-41FE-97B5-9377084163EFQ28585357-629DCDE7-7C75-4214-801E-977AC8D744E8Q28593583-3874EC1C-2673-411D-804E-92084246EE29Q30395243-320FCC04-ADD4-420F-8323-621F98C0EFD6Q30401219-FCBD76B1-DE34-4A53-B06C-F3ECD2628883Q33719306-EE698DE8-3A42-4674-91D9-AF2285D064ADQ33797938-8410752E-077C-4E0D-920D-7F43D114F159Q34094008-D23EBFB5-158F-41C7-A324-7DA5DB9166FCQ34201532-0212D54C-CDB5-435F-8CC6-168ECC8C28F4Q34372135-75C46E27-D2A9-4839-AB1F-C8266CD3C16BQ34392452-4003E391-ECEB-432C-846A-4B7D36EC0D1AQ34434662-D91539F4-897B-431E-B54E-1FDC8CDA901BQ34501600-CAB07ED6-504F-4F26-A60C-A9C4B439B045Q34629593-A38EF7B4-176E-4C3C-8D55-FABC80A316F7Q35106605-E623F7C9-05BB-43F3-924A-B56849976B80Q35968238-12495A6B-1B09-46CC-A0E9-95102D302A33Q36055535-8F36CD52-E49F-4D76-A510-9E75933A1CB3Q36445408-F6A65456-D108-4EAD-ACD5-038CD772C6D8Q36466166-46FB0C0C-221D-45A0-9545-516B729FD2CDQ36788811-E3E3569A-DED9-4F31-814A-EE5A227ECE40Q36791342-1B45DC5B-4934-49CE-B063-F32B2504C0FBQ36880238-FA7C15E0-2058-4BB4-8CD2-4E3E0E68390BQ36901098-7FB4F993-9892-47E5-873B-60C633ACD62FQ37056920-D0D199F8-75EC-49F7-AD26-2E02965F91D3Q37157765-623C9A18-9A62-48CD-A8A1-E24B1DB6A1B7Q37276280-3E0FFC7F-F31A-4215-A728-9D125D4D0F14Q37362447-EA78B038-DC7B-4F79-BD88-BCA362E516C1Q38058009-DAF984B7-0297-4A19-BC0A-B99C39CF393BQ38667290-E553CB67-CE51-453C-9400-9EA1F2572122Q39789571-986BC031-7B7A-4DC2-AC46-1D1DB2CFE59CQ40574659-94F0033E-C6A7-4EE5-82BF-401E58BF67BAQ40905804-5960A9B2-67A9-4FE9-9AAB-DC2DAE896A99Q42447206-943BD88B-C3FD-49BD-BDFC-BE6BF62A5B50Q42478324-6BAAF9E6-2F8C-4D57-B5FB-FADA5F0379C7Q42479116-47E05D64-F4B7-4363-8215-C34816E1FD9EQ42506610-73AF80B0-2C59-476C-9EFA-60C6DC463B9C
P2860
D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@en
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@nl
type
label
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@en
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@nl
prefLabel
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@en
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@nl
P2093
P1433
P1476
D1 and D2 dopamine receptors d ...... l and striatopallidal neurons.
@en
P2093
Fibiger HC
Robertson GS
Vincent SR
P304
P356
10.1016/0306-4522(92)90096-K
P407
P577
1992-07-01T00:00:00Z